1035345-27-7

Basic information

• Product Name: (4-(3-(1-methyl-1H-pyrazol-4-yl)phenyl)-1-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl)methanamine
• Synonyms: (4-(3-(1-methyl-1H-pyrazol-4-yl)phenyl)-1-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl)methanamine
• CAS NO: 1035345-27-7
• Molecular Weight: 401.514
• Mol File: 1035345-27-7.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (4-(3-(1-methyl-1H-pyrazol-4-yl)phenyl)-1-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl)methanamine(CAS DataBase Reference)
• NIST Chemistry Reference: (4-(3-(1-methyl-1H-pyrazol-4-yl)phenyl)-1-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl)methanamine(1035345-27-7)
• EPA Substance Registry System: (4-(3-(1-methyl-1H-pyrazol-4-yl)phenyl)-1-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl)methanamine(1035345-27-7)

Safety Data

• Hazardous Substances Data: 1035345-27-7(Hazardous Substances Data)

Upstream product

• 1035346-17-8 N-(diphenylmethylene)-1-(4-(3-(1-methyl-1H-pyrazol-4-yl)phenyl)piperidin-4-yl)methanamine 
• 1618-36-6 4-chloro-5-methyl-7H-pyrrolo[2,3-d]pyrimidine 

Relevant articles and documents

SUBSTITUTED PIPERIDINES CONTAINING A HETEROARYLAMIDE OR HETEROARYLPHENYL MOIETY

The invention provides compounds of the formula (I) having PKA and PKB kinase inhibiting compounds of the formula (I): GP 1 J T 2 J N 4 R N H (I) or salts, solvates, tautomers or N-oxides thereof, wherein (1) GP is a group GP1: HET 2a a Q G (HNCO)f 7 (R )x N * (GP1) (2) GP is a group GP2: 10 (R )r O 2a a QG (CH2)w N V H N * (GP2) wherein HET is a monocyclic or bicyclic heterocyclic group containing up to 4 heteroatom ring members; the ring V is a monocyclic or bicyclic heteroaryl group of 5 to 10 ring members; and J1, J2, R4, R7, R10, Q2a, Ga, x, w and f are as defined in the claims